levodopa has been researched along with cysteine in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (14.29) | 18.7374 |
| 1990's | 5 (17.86) | 18.2507 |
| 2000's | 9 (32.14) | 29.6817 |
| 2010's | 8 (28.57) | 24.3611 |
| 2020's | 2 (7.14) | 2.80 |
| Authors | Studies |
|---|---|
| Cha, SH; Chairoungdua, A; Endou, H; Kanai, Y; Kim, DK; Matsuo, H | 1 |
| Ito, S; Jimbow, K; Miura, T | 1 |
| Sławińska, D; Sławiński, J | 1 |
| Ito, S; Kasuga, T; Matsubara, O; Seki, S; Suzuki, S; Yamada, I | 1 |
| Ito, S; Ito, Y; Jimbow, K | 1 |
| Jergil, B; Lindbladh, C; Rorsman, H; Rosengren, E | 1 |
| Lunte, SM; O'Shea, TJ | 1 |
| Bertoldi, M; Castellani, S; Dominici, P; Moore, PS; Voltattorni, CB | 1 |
| Friedman, MB; Snyder, RD | 1 |
| Figueroa-Espinoza, MC; Rouau, X | 1 |
| Kowa, H; Nakashima, K; Nakaso, K; Takeshima, T; Yasui, K | 1 |
| Halliwell, B; Jenner, P; Spencer, JP; Whiteman, M | 1 |
| Bacconi, A; Forster, I; Hajnal, A; Shoemaker, CB; Skelly, PJ; Stasiuk, S; Stetak, A; Veljkovic, E; Verrey, F | 1 |
| Chillarón, J; Fernández, E; Palacín, M; Torrents, D; Zorzano, A | 1 |
| Dzoljić, E; Kostić, V; Krajinović, M; Mirković, D; Nesić, Z; Novaković, I; Prostran, M; Stojanović, R; Todorović, Z | 1 |
| Casadevall, A; Dadachova, EA; Howell, RC; Schweitzer, AD | 1 |
| Kuhn, W; Müller, T | 1 |
| Bryan, RA; Cahill, S; Casadevall, A; Chen, CC; Dadachova, E; Gerfen, G; Howell, RC; Jiang, Z; Mah, D; Schweitzer, AD | 1 |
| Kazarian, GV; L'vov, MV; Ovsepian, LM; Zakarian, GV; Zakharian, AV | 1 |
| Allen, GF; Clayton, PT; Footitt, EJ; Heales, SJ; Mills, PB; Oppenheim, M | 1 |
| Fan, T; Fan, X; Jiang, G; Jing, Z; Yu, M | 1 |
| Muhlack, S; Müller, T | 2 |
| Mueller, BK; Muhlack, S; Müller, T; Trommer, I | 1 |
| Olas, B | 1 |
| Akazawa-Ogawa, Y; Fujimura, H; Hagihara, Y; Hamakubo, T; Hara, Y; Hisahara, S; Itoh, S; Kobayashi, M; Kusunoki, S; Matsumura, A; Mita, Y; Noguchi, N; Saigoh, K; Saito, Y; Shichiri, M; Shimohama, S; Sutou, K; Takamatsu, H; Yoshida, Y | 1 |
| Correia, MAS; Gallardo, E; Gonçalves, AM; Oliveira, AE; Oliveira, DM; Passarinha, LA; Pedro, AQ; Queiroz, JA; Romão, MJ; Santos, MFA | 1 |
| Cheng, C; Luo, D; Ma, Q; Qi, L; Qiao, J | 1 |
1 review(s) available for levodopa and cysteine
| Article | Year |
|---|---|
Medical Functions of Hydrogen Sulfide.
Topics: Angiogenesis Inducing Agents; Cardiovascular Agents; Cysteine; Diclofenac; Disulfides; Heart; Humans; Hydrogen Sulfide; Kidney; Levodopa; Prostaglandins F, Synthetic; Reperfusion Injury; Sulfides; Thioctic Acid; Thiones; Vasodilator Agents | 2016 |
3 trial(s) available for levodopa and cysteine
| Article | Year |
|---|---|
Homocysteine serum levels and MTHFR C677T genotype in patients with Parkinson's disease, with and without levodopa therapy.
Topics: Adult; Aged; Aged, 80 and over; Antiparkinson Agents; Cysteine; Female; Homocysteine; Humans; Levodopa; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Parkinson Disease; Threonine; Time Factors | 2006 |
Cysteine elevation in levodopa-treated patients with Parkinson's disease.
Topics: Adult; Aged; Analysis of Variance; Antiparkinson Agents; Cohort Studies; Cysteine; Female; Glycine; Humans; Levodopa; Linear Models; Male; Middle Aged; Parkinson Disease; Severity of Illness Index | 2009 |
Levodopa increases oxidative stress and repulsive guidance molecule A levels: a pilot study in patients with Parkinson's disease.
Topics: Aged; Antiparkinson Agents; Carbidopa; Chromatography, High Pressure Liquid; Cysteine; Dipeptides; Drug Combinations; Female; GPI-Linked Proteins; Humans; Levodopa; Male; Middle Aged; Nerve Tissue Proteins; Oxidative Stress; Parkinson Disease; Pilot Projects | 2016 |
24 other study(ies) available for levodopa and cysteine
| Article | Year |
|---|---|
Expression cloning of a Na+-independent aromatic amino acid transporter with structural similarity to H+/monocarboxylate transporters.
Topics: Amino Acid Sequence; Amino Acid Transport Systems; Amino Acid Transport Systems, Neutral; Animals; Anion Transport Proteins; Bacterial Proteins; Carrier Proteins; Cloning, Molecular; Escherichia coli Proteins; Female; Intestine, Small; Kinetics; Levodopa; Mice; Molecular Sequence Data; Oocytes; Phenylalanine; Rats; Recombinant Proteins; Sequence Alignment; Sequence Homology, Amino Acid; Substrate Specificity; Tryptophan; Tyrosine; Xenopus laevis | 2001 |
The in vivo antimelanoma effect of 4-S-cysteaminylphenol and its n-acetyl derivative.
Topics: Animals; Antineoplastic Agents; Carbidopa; Cell Division; Cysteamine; Cysteine; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Kinetics; Levodopa; Melanoma, Experimental; Mice; Mice, Inbred Strains; Monophenol Monooxygenase; Neoplasm Transplantation; Phenols; Substrate Specificity | 1990 |
Ultraweak photon emission in model reactions of the in vitro formation of eumelanins and pheomelanins.
Topics: Catechol Oxidase; Chemical Phenomena; Chemistry; Cysteine; Cysteinyldopa; Dihydroxyphenylalanine; Isomerism; Kinetics; Levodopa; Luminescent Measurements; Melanins; Monophenol Monooxygenase; Oxidation-Reduction; Peroxidases | 1987 |
The cytotoxicity of cysteinylcatechols and related compounds to human melanoma cells in vitro.
Topics: Antineoplastic Agents; Catechols; Cell Division; Cell Line; Cell Survival; Cysteine; Dose-Response Relationship, Drug; Humans; Levodopa; Melanoma; Phenols; Time Factors | 1987 |
Depigmentation of black guinea pig skin by topical application of cysteaminylphenol, cysteinylphenol, and related compounds.
Topics: Animals; Cell Survival; Cysteamine; Cysteine; Epidermis; Guinea Pigs; Levodopa; Melanocytes; Skin Pigmentation; Vitiligo | 1987 |
Inactivation of human tyrosinase by cysteine. Protection by dopa and tyrosine.
Topics: Catalase; Catechol Oxidase; Cells, Cultured; Cysteine; Humans; In Vitro Techniques; Levodopa; Melanoma; Monophenol Monooxygenase; Superoxide Dismutase; Tyrosine | 1984 |
Pharmaceutical and biomedical applications of capillary electrophoresis/electrochemistry.
Topics: Animals; Blood Glucose; Brain Chemistry; Capillary Action; Cysteine; Dialysis; Electrochemistry; Electrophoresis; Glutathione; Levodopa; Peptides; Rats | 1994 |
Mutation of cysteine 111 in Dopa decarboxylase leads to active site perturbation.
Topics: 5-Hydroxytryptophan; Alanine; Animals; Base Sequence; Binding Sites; Circular Dichroism; Cysteine; Dopa Decarboxylase; Hydrogen-Ion Concentration; Kidney; Kinetics; Levodopa; Mutagenesis, Site-Directed; Pyridoxal Phosphate; Serine; Spectrometry, Fluorescence; Spectrophotometry; Structure-Activity Relationship; Swine | 1997 |
Enhancement of cytotoxicity and clastogenicity of l-DOPA and dopamine by manganese and copper.
Topics: Animals; Cell Division; Cell Line; Copper; Cricetinae; Cysteine; Dopamine; Glutathione; Levodopa; Lung; Manganese; Melanins; Micronucleus Tests; Mutagens; Parkinson Disease | 1998 |
Effect of cysteinyl caffeic acid, caffeic acid, and L-dopa on the oxidative cross-linking of feruloylated arabinoxylans by a fungal laccase.
Topics: Caffeic Acids; Cross-Linking Reagents; Cysteine; Gels; Laccase; Levodopa; Oxidation-Reduction; Oxidoreductases; Polyporaceae; Viscosity; Xylans | 1999 |
Plasma homocysteine and MTHFR C677T genotype in levodopa-treated patients with PD.
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Cysteine; Female; Folic Acid; Genotype; Homocysteine; Humans; Levodopa; Male; Methylenetetrahydrofolate Reductase (NADPH2); Middle Aged; Oxidoreductases Acting on CH-NH Group Donors; Parkinson Disease; Point Mutation | 2000 |
5-s-Cysteinyl-conjugates of catecholamines induce cell damage, extensive DNA base modification and increases in caspase-3 activity in neurons.
Topics: 3,4-Dihydroxyphenylacetic Acid; Animals; Caspase 3; Caspases; Catecholamines; Cell Survival; Cells, Cultured; Cysteine; Cysteinyldopa; DNA; Dopamine; Dose-Response Relationship, Drug; Enzyme Activation; Intracellular Fluid; Levodopa; Methamphetamine; Neurons; Purines; Pyrimidines; Rats; Reactive Oxygen Species | 2002 |
Aromatic amino acid transporter AAT-9 of Caenorhabditis elegans localizes to neurons and muscle cells.
Topics: Amino Acid Transport Systems; Amino Acids, Aromatic; Animals; Biological Transport; Caenorhabditis elegans; Cell Membrane; Cloning, Molecular; Cysteine; Disulfides; DNA, Complementary; Electrophysiology; Gene Silencing; Green Fluorescent Proteins; Humans; Immunohistochemistry; Ions; Kinetics; Levodopa; Microscopy, Fluorescence; Muscles; Neurons; Oocytes; Phenotype; Phenylalanine; Phylogeny; Plasmids; Promoter Regions, Genetic; Protein Structure, Secondary; Protein Structure, Tertiary; RNA, Complementary; Time Factors; Transgenes; Xenopus laevis | 2004 |
Identification and functional characterization of a novel low affinity aromatic-preferring amino acid transporter (arpAT). One of the few proteins silenced during primate evolution.
Topics: Alanine; Amino Acid Sequence; Amino Acid Transport Systems; Amino Acid Transport Systems, Neutral; Amino Acids; Amino Acids, Aromatic; Animals; Arginine; Biological Transport; Blotting, Northern; Blotting, Western; Cell Lineage; Chickens; Cloning, Molecular; Cysteine; Dimerization; DNA, Complementary; Dogs; Dose-Response Relationship, Drug; Evolution, Molecular; Gene Library; Gene Silencing; Glutamine; Glycine; HeLa Cells; Humans; In Situ Hybridization; Inhibitory Concentration 50; Intestine, Small; Kidney; Kinetics; Levodopa; Mice; Molecular Sequence Data; Open Reading Frames; Pan troglodytes; Phylogeny; Proline; Protein Binding; Rats; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Serine; Sodium; Transfection | 2005 |
Chemosorption of radiometals of interest to nuclear medicine by synthetic melanins.
Topics: Actinium; Adsorption; Bismuth; Cysteine; Dopamine; Gamma Rays; Indium Radioisotopes; Levodopa; Melanins; Nuclear Medicine; Radiochemistry; Scintillation Counting; Tyrosine | 2008 |
Physico-chemical evaluation of rationally designed melanins as novel nature-inspired radioprotectors.
Topics: Animals; CHO Cells; Cricetinae; Cricetulus; Cryptococcus neoformans; Cysteine; Cysteinyldopa; Free Radicals; Gamma Rays; Levodopa; Manganese Compounds; Melanins; Molecular Weight; Oxides; Oxygen; Radiation Tolerance; Radiation, Ionizing | 2009 |
[Effect of cysteine lithium salt on lipid peroxidation in the model of dopaminergic system disorder].
Topics: Animals; Antioxidants; Brain; Cysteine; Dopamine; Levodopa; Lipid Peroxidation; Lipid Peroxides; Lithium; Mitochondria; Oleic Acids; Rats | 2010 |
Pyridoxal 5'-phosphate in cerebrospinal fluid; factors affecting concentration.
Topics: Adolescent; Adult; Biopterins; Child; Child, Preschool; Cysteine; Epilepsy; False Positive Reactions; Female; Free Radicals; Humans; Infant; Infant, Newborn; Levodopa; Male; Metabolism, Inborn Errors; Middle Aged; Nervous System Diseases; Oxygen; Pyridoxal Phosphate; Reference Values; Reproducibility of Results; Sulfites; Tetrahydrofolates | 2011 |
Purification and characterization of phenoloxidase from brine shrimp Artemia sinica.
Topics: Animals; Artemia; Ascorbic Acid; Benzoic Acid; Biocatalysis; Catechol Oxidase; Catechols; Citric Acid; Copper; Cysteine; Electrophoresis, Polyacrylamide Gel; Enzyme Assays; Enzyme Inhibitors; Hydrogen-Ion Concentration; Kinetics; Levodopa; Molecular Weight; Monophenol Monooxygenase; Phenylthiourea; Substrate Specificity; Sulfites; Temperature | 2011 |
Cysteine decrease following acute Levodopa intake in patients with Parkinson's disease.
Topics: Administration, Oral; Antiparkinson Agents; Aromatic Amino Acid Decarboxylase Inhibitors; Carbidopa; Cysteine; Drug Combinations; Female; Humans; Levodopa; Male; Middle Aged; Parkinson Disease | 2012 |
Levodopa-related cysteinyl-glycine and cysteine reduction with and without catechol-O-methyltransferase inhibition in Parkinson's disease patients.
Topics: Aged; Analysis of Variance; Antiparkinson Agents; Carbidopa; Catechol O-Methyltransferase; Catechols; Chromatography, Reverse-Phase; Cysteine; Dipeptides; Drug Delivery Systems; Female; Humans; Levodopa; Male; Methyldopa; Middle Aged; Nitriles; Parkinson Disease; Time Factors | 2014 |
Oxidation and interaction of DJ-1 with 20S proteasome in the erythrocytes of early stage Parkinson's disease patients.
Topics: Aged; Animals; Cysteine; Disease Models, Animal; Erythrocytes; Female; Humans; Levodopa; Macaca fascicularis; Male; Middle Aged; Oxidative Stress; Parkinson Disease; Proteasome Endopeptidase Complex; Protein Deglycase DJ-1; Protein Multimerization | 2016 |
Thermofluor-Based Optimization Strategy for the Stabilization of Recombinant Human Soluble Catechol-
Topics: Carboxy-Lyases; Catechol O-Methyltransferase; Catechols; Cysteine; Dopamine; Estrogens; Glycerol; Humans; Ionic Liquids; Levodopa; Metanephrine; Parkinson Disease; Trehalose | 2022 |
Dipeptide-Capped Copper Nanoparticles as Chiral Nanozymes for Colorimetric Enantioselective Recognition of 3,4-Dihydroxy-d,l-phenylalanine.
Topics: Colorimetry; Copper; Cysteine; Histidine; Levodopa; Metal Nanoparticles; Peroxidases; Phenylalanine; Stereoisomerism | 2023 |